Printed from Voxsanity (voxsanity.com.au) — NCT02402244 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
AI generated eligibility summary.
Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source.
How we use AI
Who might be able to join this trial:
People who are 25 years old or younger at the time of their original diagnosis (in some cases, older ages may be accepted if the person is being considered for a specific related treatment study — confirm with trial site)
People who are enrolled within 6 months of first being diagnosed, OR within 6 months of their disease coming back, getting worse, not responding to treatment, a new cancer developing, or in some cases after death (for family involvement)
People previously enrolled in a related study called ACCRN07, who may be able to join certain parts of this registry once they reach adulthood
People with a known or suspected cancer that is classified as borderline, pre-cancerous (in situ), or malignant (confirmed cancer)
People with any type of brain or spinal cord tumour, regardless of whether it is benign, borderline, or malignant
People with any type of kidney tumour, regardless of whether it is benign, borderline, or malignant
People with certain specific conditions, including: mesoblastic nephroma, mature or immature teratomas, myeloproliferative diseases (including transient types), Langerhans cell histiocytosis, lymphoproliferative diseases, desmoid tumours, gonadal stromal cell tumours, neuroendocrine tumours (including pheochromocytoma), melanocytic tumours (except clearly benign moles), and ganglioneuromas
The patient, or their parent or legal guardian, must sign a written consent form agreeing to take part in at least one part of the study
Who may not be able to join:
People who are older than 25 at the time of their original diagnosis, unless a specific related treatment study has a higher age limit (confirm with trial site)
People who cannot be enrolled within 6 months of the relevant diagnosis or disease event, as described above
People whose tumour or condition does not fall within the categories listed in the eligibility criteria
People, or whose parents or legal guardians, are unwilling or unable to sign the required consent forms
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
Contact this trial
Principal Investigator: Douglas S Hawkins, Children's Oncology Group
Australian sites
John Hunter Children's Hospital, Hunter Regional Mail Centre, New South Wales
(02) 4985 5180
Sydney Children's Hospital, Randwick, New South Wales
(02) 9382-1721
The Children's Hospital at Westmead, Westmead, New South Wales
61-2-9845 1400
Queensland Children's Hospital, South Brisbane, Queensland
61 7 3068 1111
Women's and Children's Hospital-Adelaide, North Adelaide, South Australia
(08) 8161 7327
Royal Hobart Hospital, Saint Hobart, Tasmania
Monash Medical Center-Clayton Campus, Clayton, Victoria
(03) 9928 8111
Royal Children's Hospital, Parkville, Victoria
61 3 9345 5656
Princess Margaret Hospital for Children, Perth, Western Australia
Perth Children's Hospital, Perth, Western Australia
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Voxsanity
Clinical trials and treatments, explained plainly · voxsanity.com.au
Date:
To: My Doctor
Re: Clinical trial enquiry
I am writing to enquire about the following clinical trial which may be relevant to my care:
Trial: NCT02402244
Sponsor: Children's Oncology Group
Phase: Not Applicable
Status: Recruiting
Condition: Melanoma
More information: https://clinicaltrials.gov/study/NCT02402244
Eligibility summary (AI generated)
Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.
Who might be able to join this trial:
People who are 25 years old or younger at the time of their original diagnosis (in some cases, older ages may be accepted if the person is being considered for a specific related treatment study — confirm with trial site)
People who are enrolled within 6 months of first being diagnosed, OR within 6 months of their disease coming back, getting worse, not responding to treatment, a new cancer developing, or in some cases after death (for family involvement)
People previously enrolled in a related study called ACCRN07, who may be able to join certain parts of this registry once they reach adulthood
People with a known or suspected cancer that is classified as borderline, pre-cancerous (in situ), or malignant (confirmed cancer)
People with any type of brain or spinal cord tumour, regardless of whether it is benign, borderline, or malignant
People with any type of kidney tumour, regardless of whether it is benign, borderline, or malignant
People with certain specific conditions, including: mesoblastic nephroma, mature or immature teratomas, myeloproliferative diseases (including transient types), Langerhans cell histiocytosis, lymphoproliferative diseases, desmoid tumours, gonadal stromal cell tumours, neuroendocrine tumours (including pheochromocytoma), melanocytic tumours (except clearly benign moles), and ganglioneuromas
The patient, or their parent or legal guardian, must sign a written consent form agreeing to take part in at least one part of the study
Who may not be able to join:
People who are older than 25 at the time of their original diagnosis, unless a specific related treatment study has a higher age limit (confirm with trial site)
People who cannot be enrolled within 6 months of the relevant diagnosis or disease event, as described above
People whose tumour or condition does not fall within the categories listed in the eligibility criteria
People, or whose parents or legal guardians, are unwilling or unable to sign the required consent forms
Important: Always verify eligibility with the trial site directly before applying.
Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.
This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.
Trial details
Status
Recruiting
Phase
Not Applicable
Sponsor
Children's Oncology Group
Registry
ClinicalTrials.gov
Start date
3 November 2015
Est. completion
31 December 2030
Where this trial is recruiting
🇦🇺 Australia
🇨🇦 Canada
🇳🇿 New Zealand
Puerto Rico
🇸🇦 Saudi Arabia
🇺🇸 United States
10 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Number of patients who consented to biobanking
Can't join this trial?
Expanded access pathways
If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.